Amanda Brazis, DPM
Foot & Ankle Surgery · Herrin, ILNPI 1528354602
Payments from drug & device makers
Across 65 payments — averaging $90.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elite Orthopedics, LLC$3K
- Arthrex$1K
- Stryker$1K
- Integra Lifesciences Corporation$30
- Ferring Pharmaceuticals Inc.$29
- Fidia Pharma USA Inc.$22
- plus $168 from 11 others
What the payments were for
- Travel & lodging$2,32039%
- Food & beverage$1,34623%
- Education$2,24238%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elite Orthopedics, LLC | 24 | $2,955 |
| Arthrex | 17 | $1,353 |
| Stryker | 8 | $1,350 |
| Integra Lifesciences Corporation | 2 | $30 |
| Ferring Pharmaceuticals Inc. | 2 | $29 |
| Fidia Pharma USA Inc. | 1 | $22 |
| EBI, LLC | 1 | $20 |
| Highridge Medical LLC | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Zimvie Inc. | 1 | $17 |
| Heron Therapeutics, Inc. | 1 | $17 |
| Amgen | 1 | $15 |
| Smith+Nephew | 1 | $14 |
| AbbVie | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| In2bones USA, LLC | 1 | $12 |
| Kerecis Limited | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$731
- INFINITY ADAPTIS$267
- PROSTEP MICA$177
How this compares
$5,907 in reported general payments places this provider in the 65th percentile of 555 foot & ankle surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 32 | $2,187 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 100 | $617 |
| Gabapentin | 57 | $473 |
| Clindamycin Hcl | 33 | $302 |
| Doxycycline Hyclate | 15 | $126 |
| Methylprednisolone | 17 | $93 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $87 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $66 |
| Ibuprofen | 26 | $65 |
| Terbinafine Hcl | 15 | $53 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Herrin
- Douglas PacaccioRockford$4.3M
- Anand VoraLibertyville$3.2M
- Lowell WeilMount Prospect$2.4M
- Matthew SorensenAlgonquin$1.1M
- Edgardo Rodriguez CollazoChicago$755K
- David GarrasOrland Park$658K
- Patrick McEneaneyCary$586K
- Brian BurgessNaperville$496K
- Kyle PearsonMorris$208K
- Stephanie OexemanChicago$206K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.